Cerebral toxoplasmosis in patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab

被引：3
|
作者：
Raquel, Calle-Calle [1 ]
Lucia, Triguero-Cueva [1 ]
Carmen, Valderrama-Martin [1 ]
Ana, Romero-Villarrubia [1 ]
Antonio, Tapia-Gomez [2 ]
Juan, Pasquau-Liano [2 ]
Carmen, Arnal-Garcia [1 ]
机构：
[1] Univ Hosp Granada, Dept Neurol Virgen Nieves, Granada, Spain
[2] Univ Hosp Granada, Unit Infect Dis Virgen Nieves, Granada, Spain
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 39卷
关键词：
Alemtuzumab; Multiple sclerosis; Toxoplasmosis;
D O I：
10.1016/j.msard.2019.101885
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Efficacy of alemtuzumab in relapsing-remitting multiple sclerosis is independent of baseline status
    Coles, A. J.
    JOURNAL OF NEUROLOGY, 2007, 254 : 55 - 55
  • [22] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [23] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [24] Acute motor axonal neuropathy following alemtuzumab treatment in relapsing-remitting multiple sclerosis patient - a case report
    Hradilek, P.
    Woznicova, I.
    Slonkova, J.
    Zeman, D.
    Zapletalova, O.
    Cabal, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 344 - 344
  • [25] The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
    Alroughani, Raed
    Van Wijmeersch, Bart
    Al Khaboori, Jabber
    Alsharoqi, Isa Ahmed
    Ahmed, Samar F.
    Hassan, Ali
    Inshasi, Jihad
    Krieger, Derk W.
    Shakra, Mustafa
    Shatila, Ahmed Osman
    Szolics, Miklos
    Khallaf, Mohamed
    Ezzat, Aly
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [26] Considerations in the treatment of relapsing-remitting multiple sclerosis
    Calabresi, PA
    NEUROLOGY, 2002, 58 (08) : S10 - S22
  • [27] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis
    Miller, Aaron E.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 181 - 194
  • [28] Ponesimod for the treatment of relapsing-remitting multiple sclerosis
    Gaber, Tarek A-Z K.
    Eltemamy, Marwa
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2022, 26 (02) : 18 - 19
  • [29] Alemtuzumab Improves Contrast Sensitivity in Relapsing-Remitting Multiple Sclerosis Patients
    Balcer, Laura
    Galetta, Steven
    Maguire, Maureen
    Palmer, Jeffrey
    Margolin, David
    Rizzo, Marco
    NEUROLOGY, 2011, 76 (09) : A446 - A446
  • [30] Effect of alemtuzumab on quality of life in patients with relapsing-remitting multiple sclerosis
    Bass, Ann
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1396 - 1396
12345